Antipass Kwari

Recent publications · Crossref

5 total works indexed

1. Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study

   · 2012 · cited 343x

2. Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients

   · 2002 · cited 328x

3. Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia

   · 2013 · cited 275x

4. Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial

   · 2023 · cited 219x

5. Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias

   · 2005 · cited 182x

via Crossref · CC0

Wikidata facts